Expert consensus on maintenance treatment for metastatic colorectal cancer in China

The impact of maintenance therapy on progression-free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that maintenance therapy can significantly prolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Rui-Hua, Shen, Lin, Li, Jin, Xu, Jian-Ming, Bi, Feng, Ba, Yi, Bai, Li, Shu, Yong-Qian, Liu, Tian-Shu, Li, Yu-Hong, Bai, Chun-Mei, Yuan, Xiang-Lin, Zhang, Jun, Chen, Gong, Zhou, Ai-Ping, Yuan, Ying, Wang, Xi-Jing, Qian, Xiao-Ping, Deng, Yan-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714517/
https://www.ncbi.nlm.nih.gov/pubmed/26769299
http://dx.doi.org/10.1186/s40880-015-0067-x
Descripción
Sumario:The impact of maintenance therapy on progression-free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that maintenance therapy can significantly prolong the progression-free survival while maintain an acceptable safety profile. Based on this evidence and common treatment practice in China, we now generated one Expert Consensus on Maintenance Treatment for Metastatic Colorectal Cancer in China to further specify the necessity of maintenance therapy, suitable candidates for such treatment, and appropriate regimens.

Ejemplares similares